Organisms expend more effort when their actions can lead to rewards, as the value of the reward offsets the extra effort expended to attain them (Kool and Botvinick, 2018; Manohar et al., 2015; Niv et al., 2006; Shenhav et al., 2017). They will even do so if the extra effort does not increase the reward they receive (Glaser et al., 2016; Milstein and Dorris, 2007; Xu-Wilson et al., 2009), indicating that mere expectation of reward is enough to justify the effort cost. Motivation, which promotes this effort expenditure, has two facets: it allows actions to be directed towards goals, and it energises our actions when rewards are expected (Niv et al., 2006). These two aspects are not always coupled. For example, employees might be salaried, where a fixed reward is guaranteed irrespective of achievements, or they might receive merit-based pay that is contingent on meeting performance targets (Lazear, 2000).

Contingent rewards motivate us because we understand the causal relation between successful actions and reward. This is instrumental, in that we apply knowledge of action-outcome associations. For instance, people must realise that merit-based pay depends on their performance for it to incentivise them. In animals, dopaminergic input to dorsal striatum is necessary for instrumental motivation (Lex and Hauber, 2010b).

In contrast, reward that is independent of what an agent does might motivate us because in a variable environment, we capitalise on rewards while they are available (Niv et al., 2007). One proposed mechanism for this is that tonic dopamine encodes expected reward rate, such that in a rich environment agents are motivated to respond faster to maximise the rewards they receive (Niv et al., 2007). Equally, dopamine can be viewed as signalling an opportunity cost– time is more costly when reward is available, and so organisms act faster (Otto and Daw, 2019; Shadmehr et al., 2010). The dopaminergic drive has not only generalised motivating effects, termed vigour (Beierholm et al., 2013; Guitart-Masip et al., 2011; Niv et al., 2007), but also context-specific effects. For example, a stimulus that predicts rewards drives conditioned responses that are uncoupled with reward (Lovibond, 1981) – similar to how salary increases might improve job performance. This phenomenon, known as Pavlovian-to-Instrumental transfer, requires dopamine projections to nucleus accumbens (Hall et al., 2001; Kelley and Delfs, 1991; Talmi et al., 2008; Wassum et al., 2013; Wyvell and Berridge, 2000). Similarly, animals tend to approach stimuli associated with rewards, even in the absence of action-contingency, a behaviour called autoshaping or sign-tracking, which also relies on nucleus accumbens dopamine (Day et al., 2006; Di Ciano et al., 2001).

The dopaminergic basis of instrumental and Pavlovian motivation could potentially explain the impaired motivation seen in PD patients and the rescue of such deficits by rewards (Ang et al., 2018; Chong et al., 2015; de Wit et al., 2011; Kojovic et al., 2014). However in certain situations, motivation by reward can paradoxically be stronger in patients with low dopamine (Aarts et al., 2012; Timmer et al., 2018), making dopamine’s exact role in motivation unclear.

These two effects of contingent and expected rewards frequently overlap in real life and in previous experiments – higher stakes raise reward expectation, but also mean that actions carry more weight. However, experimental control of expectation and contingency allows them to be dissociated (Manohar et al., 2017), which reveals that both contingency and expectation can separately motivate behaviour, and that these effects are independent rather than correlated or antagonistic, suggesting distinct mechanisms.

We used this incentivised saccade task (Manohar et al., 2017) here to test PD patients ON and OFF their dopaminergic medication, along with healthy age-matched controls. We tested the two predictions that dopamine is involved in motivation by expected rewards, and by contingent rewards.

In this study, we tested two competing theories of dopaminergic motivation – that dopamine improves instrumental, contingent motivation, and that dopamine improves guaranteed reward motivation via reward expectation. Patients with PD made more vigorous responses, measured by peak saccade velocity residuals (Figure 2a), when rewards were either contingent on performance or guaranteed, but these two effects were differentially affected by dopaminergic medication. When ON medication, PD patients were motivated by rewards contingent on performance, but not by guaranteed rewards. In contrast, when patients were OFF their dopaminergic medication, the opposite pattern was observed; they were motivated by guaranteed rewards, but not by rewards contingent on performance. In this study, older healthy controls were not significantly invigorated by either guaranteed or contingent rewards, although they showed a numerically similar pattern to PD ON. Guaranteed rewards led to PD OFF having earlier increases in velocity and acceleration (Figure 3c & d), which was not seen in PD ON or when rewards were contingent, and this was accompanied by increased autocorrelation of eye position (Figure 4), suggesting increased motor noise early in the saccade. The two motivational effects were uncorrelated across people and between medication states (Figure 5) indicating that dopamine does not promote one type of motivation over another in a competitive fashion, and were not associated with changes in pupil dilatation (Figure 6). Rather, reward expectation and contingency provide distinct motivational drives (Figure 7), which can be dissociated by dopaminergic medication.

Figure 7

Download asset Open asset

The results suggest that dopamine is necessary for contingent motivation. Contingent motivation requires the use of stimulus-action-outcome associations for goal-directed behaviour (Daw and Dayan, 2014; Dickinson, 1985), while reward expectation can occur via stimulus-outcome associations (Niv et al., 2007) that do not require understanding the causal role of action. Our results align with rodent work demonstrating that dorsomedial striatum dopaminergic lesions impair action-outcome associations, such that animals continue to respond to previously rewarding cues even when action-contingency is removed (Lex and Hauber, 2010b). At a more general level, our result is also consistent with dopamine being necessary for behaviours involving a causal state-action-state model (Sharpe et al., 2017), but not simple value-guided actions (Sharp et al., 2016).

Our finding reveals that dopaminergic medication attenuates the cue-driven reward expectation effect on vigour can be contrasted with previous work suggesting that tonic dopamine couples vigour to average reward rate (Beierholm et al., 2013; Niv et al., 2007). Our adaptive reward schedule held the average reward rate constant over time, while manipulating the average reward rate within each condition, such that the guaranteed 10 p and 0 p trials had different expected rewards. Dopamine might reduce these expectation effects through a different mechanism; the guaranteed cues elicit Pavlovian signals that track expected rewards across states and cues rather than time. Our result implicates dopamine in this signalling, but the direction of effect contrasts with naïve predictions. Dopamine is necessary for Pavlovian-to-Instrumental transfer (Hall et al., 2001; Kelley and Delfs, 1991; Wyvell and Berridge, 2000) via the nucleus accumbens. In contrast, we show that reward expectation influences vigour when dopaminergic tone is low, yet does not when dopaminergic tone is high. This aligns with the finding that slow, tonic dopaminergic activity is not related to Pavlovian-to-Instrumental transfer (Wassum et al., 2013). A possible explanation is that being ON dopamine led to a saturation in tonic dopamine leaving little room for phasic cue-related reward expectation signals. But if this were the case, one might expect generally higher velocities when ON, compared to PD OFF, which was not seen. Because our contingent and random conditions were matched for average reward rate, and thus opportunity cost, invigoration by contingent reward indicates a truly instrumental effect.

An alternative explanation for the discrepancy with previous research showing dopamine encodes reward rate, is that the previous studies did not fully decouple contingent and non-contingent motivation. In many studies, expected rewards were only given for successful performance (Beierholm et al., 2013; Niv et al., 2007), meaning the rewards were still contingent on performance. However, when separated, contingent motivation has larger effects on vigour than reward expectation (Manohar et al., 2017), and so it is possible that some previously reported effects of average reward rate on vigour were due to the greater contingency, separate from or in addition to, reward expectation. Indeed, vigour may be reduced by dopamine in PD, though reward sensitivity is increased (Muhammed et al., 2016). An additional challenge to the tonic dopamine theory of reward expectation comes from the finding that fast phasic dopaminergic responses in the nucleus accumbens encode average reward rate, but slow tonic responses do not (Mohebi et al., 2019). That study suggests that reward expectation signals are independent of ventral tegmental area dopaminergic neuron firing, and may instead be due to ‘local’ control over nucleus accumbens core dopamine release. As dopamine is depleted in PD via dopamine-neuron death in the substantia nigra and ventral tegmental area, local dopamine release in other areas may be relatively preserved, and thus still able to influence vigour when PD patients are without dopamine.

The effect of reward-expectation on peak velocity was accompanied by greater velocity, acceleration, and autocorrelation early in the saccade for PD OFF than ON. Greater autocorrelation at this point is expected, as greater velocity increases noise (Harris and Wolpert, 2006; Fitts, 1954). However, this noise increase did not persist until the end of the saccade, as there was no increase in autocorrelation at the end of the saccade (Figure 4) and no greater endpoint variability (Figure 2e) – indeed, guaranteed rewards actually decreased endpoint variability, although this was not affected by dopamine. This offers some indirect evidence that the increased noise in this condition was attenuated via negative feedback (c.f. Manohar et al., 2019).

PD patients had slower saccadic RTs, and slower, smaller and more variable saccades compared to age-matched controls. The pattern of invigoration also differed from controls, who did not show significant effects of either contingent motivation or reward-expectation on speed. Instead, controls had lower motor variability when rewards were guaranteed, but no other significant motivation effects. This leads to a pattern where PD ON show contingent motivation, PD OFF show reward-expectation effects, and HC show neither. As these effects themselves are not statistically different between groups, we are limited in the conclusions that we can draw about them. Numerically, controls show a similar pattern to PD ON (Figure 2a), with faster velocity residuals for contingent rewards, which could suggest that dopaminergic medication is restoring healthy function, but care must be taken with this interpretation. The lack of either type of motivation in the older HC is surprising given that in healthy young adults, both contingent and guaranteed rewards increase saccade velocity (Manohar et al., 2017). This could suggest ageing decreases both contingent-motivation and reward-expectation, although a study directly comparing ages would be needed to conclude this.

The motivational effects reported here were not related to any pupillary responses, unlike our previous findings in young people, which may be due to both ageing and PD decreasing the influence of rewards on pupil size (Manohar and Husain, 2015; Muhammed et al., 2016). Additionally, while the two distinct motivational effects on velocity were uncorrelated within PD patients, it is possible that subgroups of patients showed different effects. For example, whether patients were on D2 agonists (Bryce and Floresco, 2019) or had tremor-dominant disease (Wojtala et al., 2019) might be relevant. However, this study was not powered to detect such differences as only six patients were taking agonists in addition to levodopa.

Considering the neuroanatomical differences between contingent motivation and reward expectation may help to explain our results. The nucleus accumbens and ventral pallidum modulate their activity by reward expectation (Mohebi et al., 2019; Tachibana and Hikosaka, 2012), while the caudate nucleus is active when rewards are contingent on behaviour (Lex and Hauber, 2010a; Tricomi et al., 2004). Both the caudate and accumbens/pallidum project to the output nuclei of the basal ganglia, allowing saccade initiation via the superior colliculus, which controls not only the direction of saccades, but also their instantaneous velocity during the movement (Smalianchuk et al., 2018). We propose contingent motivation and reward expectation both lead to motivational signals affecting the superior colliculus’ activity controlling the velocity and acceleration of saccades, and these are differentially affected by dopamine (Figure 7), although we remain agnostic as to the mechanism for this difference. Possibilities include the two systems receiving input from separate regions of the dopaminergic system which are differentially depleted in PD (e.g. dopamine overdose hypothesis [Cools, 2006]), differences in ‘global’ and ‘local’ dopamine signals (Mohebi et al., 2019), or differences in D1-like and D2-like receptor expression within these systems (Surmeier et al., 2007; Yetnikoff et al., 2014). Further studies should address this question of the underlying mechanism.

We have shown that in PD, dopaminergic medication boosts motivation by contingent rewards, but reduces motivation by expected reward. Nonspecific invigoration by reward may thus be generated by a different neural system than goal-directed motivation. This suggests that dopaminergic medication may be a potential treatment for impairments in contingent motivation, but not for deficits related to reward expectation.

Anonymised data are available on OSF (https://osf.io/2k6x3).

1. 1. Grogan JP
   2. Sandhu TR
   3. Hu MT
   4. Manohar SG

   (2020) Open Science Framework

   ID 2k6x3. Contingent Motivation in PD.

   https://osf.io/2k6x3

1. 1. Aarts E
   2. Helmich RC
   3. Janssen MJ
   4. Oyen WJ
   5. Bloem BR
   6. Cools R

   (2012) Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss

   NeuroImage 59:3339–3346.

   https://doi.org/10.1016/j.neuroimage.2011.11.073

   • PubMed
   • Google Scholar
2. 1. Ang YS
   2. Lockwood P
   3. Apps MA
   4. Muhammed K
   5. Husain M

   (2017) Distinct subtypes of apathy revealed by the apathy motivation index

   PLOS ONE 12:e0169938.

   https://doi.org/10.1371/journal.pone.0169938

   • PubMed
   • Google Scholar
3. 1. Ang YS
   2. Manohar S
   3. Plant O
   4. Kienast A
   5. Le Heron C
   6. Muhammed K
   7. Hu M
   8. Husain M

   (2018) Dopamine modulates option generation for behavior

   Current Biology 28:1561–1569.

   https://doi.org/10.1016/j.cub.2018.03.069

   • PubMed
   • Google Scholar
4. 1. Bahill AT
   2. Clark MR
   3. Stark L

   (1975) The main sequence, a tool for studying human eye movements

   Mathematical Biosciences 24:191–204.

   https://doi.org/10.1016/0025-5564(75)90075-9

   • Google Scholar
5. Conference

   1. Beck AT
   2. Steer RA
   3. Brown G

   (1996) Beck depression Inventory–II

   In the Psychological Corporation.

   https://doi.org/10.1037/t00742-000

   • Google Scholar
6. 1. Beierholm U
   2. Guitart-Masip M
   3. Economides M
   4. Chowdhury R
   5. Düzel E
   6. Dolan R
   7. Dayan P

   (2013) Dopamine modulates reward-related vigor

   Neuropsychopharmacology 38:1495–1503.

   https://doi.org/10.1038/npp.2013.48

   • PubMed
   • Google Scholar
7. 1. Blundell J
   2. Frisson S
   3. Chakrapani A
   4. Gissen P
   5. Hendriksz C
   6. Vijay S
   7. Olson A

   (2018) Oculomotor abnormalities in children with Niemann-Pick type C

   Molecular Genetics and Metabolism 123:159–168.

   https://doi.org/10.1016/j.ymgme.2017.11.004

   • PubMed
   • Google Scholar
8. 1. Bryce CA
   2. Floresco SB

   (2019) Alterations in effort-related decision-making induced by stimulation of dopamine D₁, D₂, D₃, and corticotropin-releasing factor receptors in nucleus accumbens subregions

   Psychopharmacology 236:2699–2712.

   https://doi.org/10.1007/s00213-019-05244-w

   • PubMed
   • Google Scholar
9. 1. Chong TT
   2. Bonnelle V
   3. Manohar S
   4. Veromann KR
   5. Muhammed K
   6. Tofaris GK
   7. Hu M
   8. Husain M

   (2015) Dopamine enhances willingness to exert effort for reward in Parkinson's disease

   Cortex 69:40–46.

   https://doi.org/10.1016/j.cortex.2015.04.003

   • PubMed
   • Google Scholar
10. Preprint

    1. Codol O
    2. Holland PJ
    3. Manohar SG
    4. Galea JM

    (2019) Reward-based improvements in motor control are driven by multiple error-reducing mechanisms

    bioRxiv.

    https://doi.org/10.1101/792598

    • Google Scholar
11. 1. Codol O
    2. Holland PJ
    3. Manohar SG
    4. Galea JM

    (2020) Reward-Based improvements in motor control are driven by multiple Error-Reducing mechanisms

    The Journal of Neuroscience 40:3604–3620.

    https://doi.org/10.1523/JNEUROSCI.2646-19.2020

    • PubMed
    • Google Scholar
12. 1. Cools R

    (2006) Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease

    Neuroscience & Biobehavioral Reviews 30:1–23.

    https://doi.org/10.1016/j.neubiorev.2005.03.024

    • PubMed
    • Google Scholar
13. 1. Daw ND
    2. Dayan P

    (2014) The algorithmic anatomy of model-based evaluation

    Philosophical Transactions of the Royal Society B: Biological Sciences 369:20130478.

    https://doi.org/10.1098/rstb.2013.0478

    • Google Scholar
14. 1. Day JJ
    2. Wheeler RA
    3. Roitman MF
    4. Carelli RM

    (2006) Nucleus accumbens neurons encode pavlovian approach behaviors: evidence from an autoshaping paradigm

    European Journal of Neuroscience 23:1341–1351.

    https://doi.org/10.1111/j.1460-9568.2006.04654.x

    • PubMed
    • Google Scholar
15. 1. de Wit S
    2. Barker RA
    3. Dickinson AD
    4. Cools R

    (2011) Habitual versus goal-directed action control in parkinson disease

    Journal of Cognitive Neuroscience 23:1218–1229.

    https://doi.org/10.1162/jocn.2010.21514

    • PubMed
    • Google Scholar
16. 1. Di Ciano P
    2. Cardinal RN
    3. Cowell RA
    4. Little SJ
    5. Everitt BJ

    (2001) Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior

    The Journal of Neuroscience 21:9471–9477.

    https://doi.org/10.1523/JNEUROSCI.21-23-09471.2001

    • PubMed
    • Google Scholar
17. 1. Dickinson A

    (1985) Actions and habits : the development of behavioural autonomy

    Philosophical Transactions of the Royal Society B 308:67–78.

    https://doi.org/10.1098/rstb.1985.0010

    • Google Scholar
18. 1. Faul F
    2. Erdfelder E
    3. Buchner A
    4. Lang AG

    (2009) Statistical power analyses using G*power 3.1: tests for correlation and regression analyses

    Behavior Research Methods 41:1149–1160.

    https://doi.org/10.3758/BRM.41.4.1149

    • PubMed
    • Google Scholar
19. 1. Fitts PM

    (1954) The information capacity of the human motor system in controlling the amplitude of movement

    Journal of Experimental Psychology 47:381–391.

    https://doi.org/10.1037/h0055392

    • PubMed
    • Google Scholar
20. 1. Glaser JI
    2. Wood DK
    3. Lawlor PN
    4. Ramkumar P
    5. Kording KP
    6. Segraves MA

    (2016) Role of expected reward in frontal eye field during natural scene search

    Journal of Neurophysiology 116:645–657.

    https://doi.org/10.1152/jn.00119.2016

    • Google Scholar
21. 1. Guitart-Masip M
    2. Beierholm UR
    3. Dolan R
    4. Duzel E
    5. Dayan P

    (2011) Vigor in the face of fluctuating rates of reward: an experimental examination

    Journal of Cognitive Neuroscience 23:3933–3938.

    https://doi.org/10.1162/jocn_a_00090

    • PubMed
    • Google Scholar
22. 1. Hall J
    2. Parkinson JA
    3. Connor TM
    4. Dickinson A
    5. Everitt BJ

    (2001) Involvement of the central nucleus of the amygdala and nucleus accumbens core in mediating pavlovian influences on instrumental behaviour

    European Journal of Neuroscience 13:1984–1992.

    https://doi.org/10.1046/j.0953-816x.2001.01577.x

    • PubMed
    • Google Scholar
23. 1. Harris CM
    2. Wolpert DM

    (1998) Signal-dependent noise determines motor planning

    Nature 394:780–784.

    https://doi.org/10.1038/29528

    • PubMed
    • Google Scholar
24. 1. Harris CM
    2. Wolpert DM

    (2006) The main sequence of saccades optimizes Speed-accuracy Trade-off

    Biological Cybernetics 95:21–29.

    https://doi.org/10.1007/s00422-006-0064-x

    • Google Scholar
25. 1. Kelley AE
    2. Delfs JM

    (1991) Dopamine and conditioned reinforcement. I. differential effects of amphetamine microinjections into striatal subregions

    Psychopharmacology 103:187–196.

    https://doi.org/10.1007/BF02244202

    • PubMed
    • Google Scholar
26. 1. Kleiner M
    2. Brainard D
    3. Pelli D
    4. Ingling A
    5. Murray R
    6. Broussard C
    7. Cornelissen F

    (2007)

    What’s new in Psychtoolbox-3? A free cross-platform toolkit for Psychophysics with Matlab & GNU/Octave

    Perception 36:1.

    • Google Scholar
27. 1. Kojovic M
    2. Mir P
    3. Trender-Gerhard I
    4. Schneider SA
    5. Pareés I
    6. Edwards MJ
    7. Bhatia KP
    8. Jahanshahi M

    (2014) Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication

    Journal of Neurology 261:1080–1089.

    https://doi.org/10.1007/s00415-014-7315-x

    • PubMed
    • Google Scholar
28. 1. Kool W
    2. Botvinick M

    (2018) Mental labour

    Nature Human Behaviour 2:899–908.

    https://doi.org/10.1038/s41562-018-0401-9

    • Google Scholar
29. 1. Lazear EP

    (2000) Performance pay and productivity

    American Economic Review 90:1346–1361.

    https://doi.org/10.1257/aer.90.5.1346

    • Google Scholar
30. 1. Lex B
    2. Hauber W

    (2010a) The role of dopamine in the prelimbic cortex and the dorsomedial striatum in instrumental conditioning

    Cerebral Cortex 20:873–883.

    https://doi.org/10.1093/cercor/bhp151

    • PubMed
    • Google Scholar
31. 1. Lex B
    2. Hauber W

    (2010b) The role of nucleus accumbens dopamine in outcome encoding in instrumental and pavlovian conditioning

    Neurobiology of Learning and Memory 93:283–290.

    https://doi.org/10.1016/j.nlm.2009.11.002

    • PubMed
    • Google Scholar
32. 1. Lovibond PF

    (1981) Appetitive Pavlovian-Instrumental interactions: effects of Inter-Stimulus interval and baseline reinforcement conditions

    The Quarterly Journal of Experimental Psychology Section B 33:257–269.

    https://doi.org/10.1080/14640748108400811

    • Google Scholar
33. 1. Manohar SG
    2. Chong TT
    3. Apps MA
    4. Batla A
    5. Stamelou M
    6. Jarman PR
    7. Bhatia KP
    8. Husain M

    (2015) Reward pays the cost of noise reduction in motor and cognitive control

    Current Biology 25:1707–1716.

    https://doi.org/10.1016/j.cub.2015.05.038

    • PubMed
    • Google Scholar
34. 1. Manohar SG
    2. Finzi RD
    3. Drew D
    4. Husain M

    (2017) Distinct motivational effects of contingent and noncontingent rewards

    Psychological Science 28:1016–1026.

    https://doi.org/10.1177/0956797617693326

    • PubMed
    • Google Scholar
35. 1. Manohar SG
    2. Muhammed K
    3. Fallon SJ
    4. Husain M

    (2019) Motivation dynamically increases noise resistance by internal feedback during movement

    Neuropsychologia 123:19–29.

    https://doi.org/10.1016/j.neuropsychologia.2018.07.011

    • PubMed
    • Google Scholar
36. Software

    1. Manohar SG

    (2020) Matlib

    GitHub.

    https://github.com/sgmanohar/matlib
37. 1. Manohar SG
    2. Husain M

    (2015) Reduced pupillary reward sensitivity in Parkinson’s disease

    Npj Parkinson’s Disease 1:20–23.

    https://doi.org/10.1038/npjparkd.2015.26

    • Google Scholar
38. 1. Martínez-Martín P
    2. Rodríguez-Blázquez C
    3. Mario Alvarez
    4. Arakaki T
    5. Arillo VC
    6. Chaná P
    7. Fernández W
    8. Garretto N
    9. Martínez-Castrillo JC
    10. Rodríguez-Violante M
    11. Serrano-Dueñas M
    12. Ballesteros D
    13. Rojo-Abuin JM
    14. Chaudhuri KR
    15. Merello M

    (2015) parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale

    Parkinsonism & Related Disorders 21:50–54.

    https://doi.org/10.1016/j.parkreldis.2014.10.026

    • PubMed
    • Google Scholar
39. 1. Milstein DM
    2. Dorris MC

    (2007) The influence of expected value on saccadic preparation

    Journal of Neuroscience 27:4810–4818.

    https://doi.org/10.1523/JNEUROSCI.0577-07.2007

    • PubMed
    • Google Scholar
40. 1. Mohebi A
    2. Pettibone JR
    3. Hamid AA
    4. Wong JT
    5. Vinson LT
    6. Patriarchi T
    7. Tian L
    8. Kennedy RT
    9. Berke JD

    (2019) Dissociable dopamine dynamics for learning and motivation

    Nature 570:65–70.

    https://doi.org/10.1038/s41586-019-1235-y

    • PubMed
    • Google Scholar
41. 1. Muhammed K
    2. Manohar S
    3. Ben Yehuda M
    4. Chong TT
    5. Tofaris G
    6. Lennox G
    7. Bogdanovic M
    8. Hu M
    9. Husain M

    (2016) Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease

    Brain 139:2706–2721.

    https://doi.org/10.1093/brain/aww188

    • PubMed
    • Google Scholar
42. 1. Muhammed K
    2. Dalmaijer E
    3. Manohar S
    4. Husain M

    (2020) Voluntary modulation of saccadic peak velocity associated with individual differences in motivation

    Cortex 122:198–212.

    https://doi.org/10.1016/j.cortex.2018.12.001

    • PubMed
    • Google Scholar
43. 1. Niv Y
    2. Joel D
    3. Dayan P

    (2006) A normative perspective on motivation

    Trends in Cognitive Sciences 10:375–381.

    https://doi.org/10.1016/j.tics.2006.06.010

    • PubMed
    • Google Scholar
44. 1. Niv Y
    2. Daw ND
    3. Joel D
    4. Dayan P

    (2007) Tonic dopamine: opportunity costs and the control of response vigor

    Psychopharmacology 191:507–520.

    https://doi.org/10.1007/s00213-006-0502-4

    • PubMed
    • Google Scholar
45. 1. Otto AR
    2. Daw ND

    (2019) The opportunity cost of time modulates cognitive effort

    Neuropsychologia 123:92–105.

    https://doi.org/10.1016/j.neuropsychologia.2018.05.006

    • Google Scholar
46. 1. Shadmehr R
    2. Orban de Xivry JJ
    3. Xu-Wilson M
    4. Shih TY

    (2010) Temporal discounting of reward and the cost of time in motor control

    Journal of Neuroscience 30:10507–10516.

    https://doi.org/10.1523/JNEUROSCI.1343-10.2010

    • PubMed
    • Google Scholar
47. 1. Sharp ME
    2. Foerde K
    3. Daw ND
    4. Shohamy D

    (2016) Dopamine selectively remediates 'model-based' reward learning: a computational approach

    Brain 139:355–364.

    https://doi.org/10.1093/brain/awv347

    • PubMed
    • Google Scholar
48. 1. Sharpe MJ
    2. Chang CY
    3. Liu MA
    4. Batchelor HM
    5. Mueller LE
    6. Jones JL
    7. Niv Y
    8. Schoenbaum G

    (2017) Dopamine transients are sufficient and necessary for acquisition of model-based associations

    Nature Neuroscience 20:735–742.

    https://doi.org/10.1038/nn.4538

    • Google Scholar
49. 1. Shenhav A
    2. Musslick S
    3. Lieder F
    4. Kool W
    5. Griffiths TL
    6. Cohen JD
    7. Botvinick MM

    (2017) Toward a rational and mechanistic account of mental effort

    Annual Review of Neuroscience 40:99–124.

    https://doi.org/10.1146/annurev-neuro-072116-031526

    • PubMed
    • Google Scholar
50. 1. Smalianchuk I
    2. Jagadisan UK
    3. Gandhi NJ

    (2018) Instantaneous midbrain control of saccade velocity

    The Journal of Neuroscience 38:10156–10167.

    https://doi.org/10.1523/JNEUROSCI.0962-18.2018

    • PubMed
    • Google Scholar
51. 1. Surmeier DJ
    2. Ding J
    3. Day M
    4. Wang Z
    5. Shen W

    (2007) D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons

    Trends in Neurosciences 30:228–235.

    https://doi.org/10.1016/j.tins.2007.03.008

    • PubMed
    • Google Scholar
52. 1. Tachibana Y
    2. Hikosaka O

    (2012) The primate ventral pallidum encodes expected reward value and regulates motor action

    Neuron 76:826–837.

    https://doi.org/10.1016/j.neuron.2012.09.030

    • PubMed
    • Google Scholar
53. 1. Talmi D
    2. Seymour B
    3. Dayan P
    4. Dolan RJ

    (2008) Human pavlovian-instrumental transfer

    Journal of Neuroscience 28:360–368.

    https://doi.org/10.1523/JNEUROSCI.4028-07.2008

    • PubMed
    • Google Scholar
54. 1. Timmer MHM
    2. Aarts E
    3. Esselink RAJ
    4. Cools R

    (2018) Enhanced motivation of cognitive control in Parkinson's disease

    European Journal of Neuroscience 48:2374–2384.

    https://doi.org/10.1111/ejn.14137

    • PubMed
    • Google Scholar
55. 1. Tricomi EM
    2. Delgado MR
    3. Fiez JA

    (2004) Modulation of caudate activity by action contingency

    Neuron 41:281–292.

    https://doi.org/10.1016/S0896-6273(03)00848-1

    • PubMed
    • Google Scholar
56. 1. Van Opstal AJ
    2. Van Gisbergen JA
    3. Smit AC

    (1990) Comparison of saccades evoked by visual stimulation and collicular electrical stimulation in the alert monkey

    Experimental Brain Research 79:299–312.

    https://doi.org/10.1007/BF00608239

    • PubMed
    • Google Scholar
57. 1. Wassum KM
    2. Ostlund SB
    3. Loewinger GC
    4. Maidment NT

    (2013) Phasic mesolimbic dopamine release tracks reward seeking during expression of Pavlovian-to-instrumental transfer

    Biological Psychiatry 73:747–755.

    https://doi.org/10.1016/j.biopsych.2012.12.005

    • PubMed
    • Google Scholar
58. 1. Wojtala J
    2. Heber IA
    3. Neuser P
    4. Heller J
    5. Kalbe E
    6. Rehberg SP
    7. Storch A
    8. Linse K
    9. Schneider C
    10. Gräber S
    11. Berg D
    12. Dams J
    13. Balzer-Geldsetzer M
    14. Hilker-Roggendorf R
    15. Oberschmidt C
    16. Baudrexel S
    17. Witt K
    18. Schmidt N
    19. Deuschl G
    20. Mollenhauer B
    21. Trenkwalder C
    22. Liepelt-Scarfone I
    23. Spottke A
    24. Roeske S
    25. Wüllner U
    26. Wittchen H-U
    27. Riedel O
    28. Dodel R
    29. Schulz JB
    30. Reetz K

    (2019) Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognition

    Journal of Neurology, Neurosurgery & Psychiatry 90:171–179.

    https://doi.org/10.1136/jnnp-2018-319008

    • Google Scholar
59. 1. Wyvell CL
    2. Berridge KC

    (2000) Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward "wanting" without enhanced "liking" or response reinforcement

    The Journal of Neuroscience 20:8122–8130.

    https://doi.org/10.1523/JNEUROSCI.20-21-08122.2000

    • PubMed
    • Google Scholar
60. 1. Xu-Wilson M
    2. Zee DS
    3. Shadmehr R

    (2009) The intrinsic value of visual information affects saccade velocities

    Experimental Brain Research 196:475–481.

    https://doi.org/10.1007/s00221-009-1879-1

    • PubMed
    • Google Scholar
61. 1. Yetnikoff L
    2. Lavezzi HN
    3. Reichard RA
    4. Zahm DS

    (2014) An update on the connections of the ventral mesencephalic dopaminergic complex

    Neuroscience 282:23–48.

    https://doi.org/10.1016/j.neuroscience.2014.04.010

    • PubMed
    • Google Scholar
62. 1. Zigmond AS
    2. Snaith RP

    (1983) The hospital anxiety and depression scale

    Acta Psychiatrica Scandinavica 67:361–370.

    https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

    • PubMed
    • Google Scholar

Acceptance summary:

The manuscript describes a unique and elegantly designed experiment to parse the role of dopamine in reward learning using human subjects – namely, patients with Parkinson's Disease, on and off dopaminergic medication. The results are novel, showing that patients with Parkinson's Disease that were ON medication had greater response vigor for contingent rewards; while those OFF medication had greater vigor for guaranteed rewards. These findings support the long-standing notion that reward expectation and contingency learning represent distinct motivational and neurobiological processes.

Decision letter after peer review:

Thank you for submitting your article "Dopamine promotes instrumental motivation, but reduces reward-related vigour" for consideration by eLife. Your article has been reviewed by two peer reviewers, including Shelly B Flagel as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Michael Frank as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Roshan Cools (Reviewer #2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as eLife papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.

Summary:

This is a timely paper on a topic of great interest with intriguing findings that incidentally also reconcile some paradoxical findings in extant literature. A clever novel rewarded saccade task was used to disentangle effects of dopaminergic medication in Parkinson's disease on two distinct types of motivation: contingent (instrumental) motivation, where reward depends on performance versus non-contingent (non-instrumental) motivation, where reward is guaranteed. Results reveal a unique double dissociation, with contingent motivation (indexed by peak velocity) being greater ON than OFF meds, but noncontingent motivation being greater OFF than ON meds. Thus PD patients OFF their medication showed a positive effect of non-contingent reward on vigor, but no effect of contingency, whereas the same patients ON their dopaminergic medication showed a positive effect of contingent vs non-contingent reward on vigor, but no effect of non-contingent reward.

This is a robust set of findings and a beautiful cross-over effect, not often seen, obtained using a well-controlled paradigm. The authors provide thorough auxiliary and control analyses to validate the specificity of their effect of interest.

Revisions:

Some concerns raised by both reviewers, regarding data analysis, interpretation and conclusions are outlined below. Of particular note, the authors need to better incorporate the reported findings into the extant literature.

1) Given the involvement of dopamine in "expectation", did the authors investigate any potential impact of order effects? That is, if the subjects were tested ON or OFF medication first, did that impact subsequent responding? It may be that the sample size is too low for this analysis and/or for the correlations to be meaningful; nonetheless, this possibility should be discussed.

2) As peak saccade velocity residuals were the primary outcome measure affected, this metric warrants further description and justification in the primary text, prior to the results.

3) It seems that HC subjects are not included in the primary analyses, but only compared to PD ON and PD OFF, in separate analyses, in the supplemental text. HC subjects should be included in the primary analyses, as they are shown in Figure 2. In relation, the authors should further interpret the fact that HC subjects differ from PD patients on measures of amplitude, saccadic RT and endpoint variability, but seem to resemble PD ON for peak velocity residuals (as shown in Figure 2). While the authors briefly discuss the negative results in HC subjects, it is not clear why there is no effect of motivation in these subjects, as one might expect. The pattern observed in HC subjects might help to explain the data from the PD subjects and therefore should be better incorporated into the manuscript. HC data should be included in Figure 3 and the accompanying analyses, as well.

4) Additional "discussion should be provided regarding the conclusion that these data suggest that dopamine is necessary only for model-based, and not model-free learning; as there are other potential explanations; especially since the HC data don't seem to support model-based learning in this task.

5) Considerable parts of the Introduction and Discussion should be rewritten. Specifically, the data do not undermine the (i) theory that dopamine is key for reward expectation (Abstract: “challenging the theory that tonic dopamine encodes reward expectation”) or (ii) average reward rate (Discussion: “this contrasts with previous research which suggests tonic dopamine encode the average reward rate”) or (iii) model-free behavior (“thus the work fits with previous research in which dopamine is necessary only for model-based, not model-free learning”). These conclusions are not supported by the current findings, because:

i) Detrimental effects of dopamine implicate dopamine as much as do beneficial effects as the authors conclude later on in the discussion.

ii) Average reward rate was not manipulated and its effects not measured. Related to this issue, I do not think that the Niv view is optimally characterized by attributing to it the prediction that dopamine would leave contingent motivation unaltered.

iii) The noncontingent Pavlovian procedure tested here doesn't address model-free learning, as measured in the papers referenced. Moreover, evidence for impaired model-based vs intact model-free control in PD (first evidenced by de Wit et al. in JoCN) is not directly relevant here, given the fairly wide gap between the type of inference that is measured in e.g. the two-step task and similar other learning tasks and the contingent reward motivation manipulation measured here.

Some of these conclusions (e.g. (i)) also counter the hypothesis put forward later in the discussion and illustrated in Figure 6 about the two forms of motivation implicating distinct dopaminergic mechanisms.

6) Two sets of literature that are directly relevant to this research are absent from the manuscript and need to be incorporated.

• The first is (pharmacological and lesion) evidence from work with experimental rodents, but also humans, on dopamine's role in the Pavlovian control of behavior, e.g. on conditioned reinforcement (Parkinson et al; Taylor and Robbins), Pavlovian-to-instrumental transfer (Dickinson et al., 2001; Wyvell and Berridge, 2000; Talmi et al., 2008), autoshaping, goal vs sign tracking etcetera.

• The second is prior evidence for enhanced effects of reward motivation in PD patients OFF but not ON meds in a manner that depends on dopamine cell loss (Aarts et al., 2012, and Timmer et al., 2018). The Introduction should reflect this prior evidence. In fact, the rationale for the current study is strengthened by the apparent discrepancy between this evidence for enhanced motivation in PD OFF meds (somewhat reminiscent of paradoxical kinesia) and the evidence previously obtained by the authors for reduced motivation in PD OFF meds.

7) The current version of the Introduction (as well as some of the Discussion) is structured based a contrast between model-based versus Pavlovian control of behavior that does not do justice our understanding of these concepts from classic learning theory. For example, the statement that “Motivation by reward expectation, independent of what an agent does, is model-free” should be rephrased. Pavlovian control can be model-free or model-based (Dayan and Berridge, 2014, CABN or Bornstein and Daw, 2011, Curr Opin Neurobiol). Related to this is my issue with the conclusion in the Discussion (see above).

8) Some of the statistical choices need to be justified and, data presentation optimized.

• The use of peak velocity residuals, corrected for amplitude, should be justified more clearly.

• It would also be good to clarify the rationale for using these residuals rather than correcting the velocities for amplitude with a covariate of no interest e.g. in a trial-wise mixed linear regression analysis.

• The use of mixed linear modeling would allow both between- as well as within-subject variability to be taken into account. Was this considered?

• I suggest that readers get access to uncorrected, observed velocity data rather than only the residuals.

• While individual datapoints are presented in the supplement, I see no principled reason to present aggregate dataplots in the main text. Why not move the supplementary figures with actual datapoints to the main text? Raincloud plots might increase the readability of these plots?

Revisions:

Some concerns raised by both reviewers, regarding data analysis, interpretation and conclusions are outlined below. Of particular note, the authors need to better incorporate the reported findings into the extant literature.

We thank the reviewers for their time and their helpful comments. We have addressed all of them, and believe it has made the manuscript more robust and readable. We address each of the points below.

When adding individual data points and HC data to some figures, we had to split some figures into new separate ones. We also noticed that some participants had not been excluded from the autocorrelation and pupillometry data, so have redone those analyses to match the exclusions applied to the other data. This has resulted in a new cluster of significance in PD OFF which matches up with the previous ON vs OFF difference, so has not changed our findings. We also corrected a typo in the demographics Table 3 (PD ACE was wrong), and have moved legends and tables to the end of this file and uploaded figures separately as requested by eLife editorial support.

1) Given the involvement of dopamine in "expectation", did the authors investigate any potential impact of order effects? That is, if the subjects were tested ON or OFF medication first, did that impact subsequent responding? It may be that the sample size is too low for this analysis and/or for the correlations to be meaningful; nonetheless, this possibility should be discussed.

We agree with the reviewer that order effects could be important. Including which session (ON/OFF) was performed first as a factor in the analysis revealed no effects of session order, or any interactions with session order, on any of the saccade measures reported. We have stated this in the Results section:

“We additionally checked whether there were practice effects in the PD patients, in case patients behaved differently on their second session due to different expectations. We found no effects or interactions of session on any measure in PD patients (p >.05).”

2) As peak saccade velocity residuals were the primary outcome measure affected, this metric warrants further description and justification in the primary text, prior to the results.

We have further explained this measure:

“A saccade’s velocity is tightly governed by its amplitude, a relation known as the “main sequence” (Bahill, Clark and Stark, 1975). […] We did this regression for each participant and session separately, but across conditions.”

We have also added a panel to Figure 1 to have an illustrative example of residuals using sample data, and have updated the legend to:

“Example of the main sequence and velocity residuals – the points show a subset of individual trials illustrating the “main sequence” relationship where larger saccades have greater velocity, shown by the regression line. The distance from each point to its line is the velocity residual, which we take as out main measure of response vigour.”

3) It seems that HC subjects are not included in the primary analyses, but only compared to PD ON and PD OFF, in separate analyses, in the supplemental text. HC subjects should be included in the primary analyses, as they are shown in Figure 2. In relation, the authors should further interpret the fact that HC subjects differ from PD patients on measures of amplitude, saccadic RT and endpoint variability, but seem to resemble PD ON for peak velocity residuals (as shown in Figure 2). While the authors briefly discuss the negative results in HC subjects, it is not clear why there is no effect of motivation in these subjects, as one might expect. The pattern observed in HC subjects might help to explain the data from the PD subjects and therefore should be better incorporated into the manuscript. HC data should be included in Figure 3 and the accompanying analyses, as well.

We agree with the reviewers that it would be useful to add interpretation to the HC results. We have therefore moved the paragraphs describing the HC-only findings to earlier in the first Results section, and rewritten it to be clearer. We have explained why residual velocity did not show a main effect of PD vs HC, and added a sentence evaluating the comparison to HC in the Results section:

“The HC peak velocity residuals were not affected by contingency, motivation or the interaction (p >.05; see Table 2), suggesting that healthy older adults do not adjust their response vigour for contingent or guaranteed rewards. […] HC did not significantly differ from PD ON or OFF in peak velocity residuals, although their pattern was numerically closest to PD ON with greater contingent motivation.”

And have expanded the Discussion of these results:

“PD patients had slower saccadic RTs, and slower, smaller and more variable saccades compared to age-matched controls. […]This could suggest ageing decreases both contingent motivation and reward-expectation, although a study directly comparing ages would be needed to conclude this.”

We have added HC data to all data figures, and the accompanying analyses. We have moved the autocorrelation data to a new separate figure in order to include the HC data, and we now present two correlation matrices (for contingent and guaranteed reward effects) for each group (PD ON, OFF, HC) and the ON-OFF difference.

4) Additional "discussion should be provided regarding the conclusion that these data suggest that dopamine is necessary only for model-based, and not model-free learning; as there are other potential explanations; especially since the HC data don't seem to support model-based learning in this task.

We have rewritten this part of the discussion, discussing PIT and instrumental model-free associations, and have clarified that model-based associations are only one possibility here:

“The results suggest that dopamine is necessary for contingent motivation. […] At a more general level, our result is also consistent with dopamine being necessary for behaviours involving a causal state-action-state model (Sharpe et al., 2017), but not simple value-guided actions (Sharp et al., 2016).”

5) Considerable parts of the Introduction and Discussion should be rewritten. Specifically, the data do not undermine the (i) theory that dopamine is key for reward expectation (Abstract: “challenging the theory that tonic dopamine encodes reward expectation”) or (ii) average reward rate (Discussion: “this contrasts with previous research which suggests tonic dopamine encode the average reward rate”) or (iii) model-free behavior (“thus the work fits with previous research in which dopamine is necessary only for model-based, not model-free learning”). These conclusions are not supported by the current findings, because:

i) Detrimental effects of dopamine implicate dopamine as much as do beneficial effects as the authors conclude later on in the discussion.

We have thought carefully about the interpretation of our findings, and we agree with the reviewers that our main result does not fit exactly where we placed it relative to the extensive animal literature.

We have changed this claim:

“We posit that dopamine promotes goal-directed motivation, but dampens reward-driven vigour, contradictory to the prediction that increased tonic dopamine amplifies reward expectation.”

ii) Average reward rate was not manipulated and its effects not measured. Related to this issue, I do not think that the Niv view is optimally characterized by attributing to it the prediction that dopamine would leave contingent motivation unaltered.

The reviewer correctly argues that although we manipulated the average reward rates between conditions, the reward rate over time was not manipulated. It is therefore not possible for us to directly address the Niv view. We have clarified this and added a sentence pointing out this difference may be relevant for the lack of effect. We also mention that the fact dopamine reduces guaranteed motivation is in fact consistent with dopamine’s being involved with this kind of motivation:

“Our finding that dopaminergic medication attenuates the cue-driven reward expectation effect on vigour can be contrasted with previous work suggesting that tonic dopamine couples vigour to average reward rate (Beierholm et al., 2013; Niv et al., 2007). […] Because our contingent and random conditions were matched for average reward rate, and thus opportunity cost, invigoration by contingent reward indicates a truly instrumental effect.”

iii) The noncontingent Pavlovian procedure tested here doesn't address model-free learning, as measured in the papers referenced. Moreover, evidence for impaired model-based vs intact model-free control in PD (first evidenced by de Wit et al. in JoCN) is not directly relevant here, given the fairly wide gap between the type of inference that is measured in e.g. the two-step task and similar other learning tasks and the contingent reward motivation manipulation measured here.

We have shifted our focus away from “model-based vs model-free” and acknowledge that our task does not help understand the traditional distinction between forward planning vs reinforcement learning. We now clarify that the task is probing motivation through action-outcome knowledge, and is related to Pavlovian vs instrumental drives (see response to point 4 for pasted text).

Some of these conclusions (e.g. (i)) also counter the hypothesis put forward later in the discussion and illustrated in Figure 6 about the two forms of motivation implicating distinct dopaminergic mechanisms.

We have adjusted these claims, and believe the new literature added to the discussion fits with the proposal of two separate systems.

6) Two sets of literature that are directly relevant to this research are absent from the manuscript and need to be incorporated.

• The first is (pharmacological and lesion) evidence from work with experimental rodents, but also humans, on dopamine's role in the Pavlovian control of behavior, e.g. on conditioned reinforcement (Parkinson et al; Taylor and Robbins), Pavlovian-to-instrumental transfer (Dickinson et al., 2001; Wyvell and Berridge, 2000; Talmi et al., 2008), autoshaping, goal vs sign tracking etcetera.

• The second is prior evidence for enhanced effects of reward motivation in PD patients OFF but not ON meds in a manner that depends on dopamine cell loss (Aarts et al., 2012 and Timmer et al., 2018). The Introduction should reflect this prior evidence. In fact, the rationale for the current study is strengthened by the apparent discrepancy between this evidence for enhanced motivation in PD OFF meds (somewhat reminiscent of paradoxical kinesia) and the evidence previously obtained by the authors for reduced motivation in PD OFF meds.

We thank the reviewers for pointing out these highly relevant bodies of literature. We have rewritten the Introduction to reflect this, and added them to the Discussion (see above):

“Contingent rewards motivate us because we understand the causal relation between successful actions and reward. […] We tested the two predictions that dopamine is involved in motivation by expected rewards, and by contingent rewards.”

7) The current version of the Introduction (as well as some of the discussion) is structured based a contrast between model-based versus Pavlovian control of behavior that does not do justice our understanding of these concepts from classic learning theory. For example, the statement that “Motivation by reward expectation, independent of what an agent does, is model-free” should be rephrased. Pavlovian control can be model-free or model-based (Dayan and Berridge, 2014, CABN or Bornstein and Daw, 2011, Curr Opin Neurobiol). Related to this is my issue with the conclusion in the Discussion (see above).

We thank the reviewer for advising on these very relevant distinctions, which we now make in our narrative. We have rewritten the Introduction and the discussion to modify these claims. We had previously attempted to suggest that model-based reasoning could underlie the PD ON benefit, although we were not clear enough that this was only one possibility. We have refocused the paper on the more clear distinction between goal-directed action-outcome and Pavlovian stimulus-outcome associations (see responses above).

8) Some of the statistical choices need to be justified and, data presentation optimized.

• The use of peak velocity residuals, corrected for amplitude, should be justified more clearly.

We have justified this (please see response to point 2 above).

• It would also be good to clarify the rationale for using these residuals rather than correcting the velocities for amplitude with a covariate of no interest e.g. in a trial-wise mixed linear regression analysis.

We have added the following to the Materials and methods section, justifying our use of residuals in ANOVA:

“To remove the main sequence effect of amplitude on velocity (Bahill et al., 1975; Harris and Wolpert, 2006), we regressed velocity against amplitude and took the peak velocity residuals as our measure of interest. […] Our findings did not qualitatively change when we used the covariate approach instead.”

• The use of mixed linear modeling would allow both between- as well as within-subject variability to be taken into account. Was this considered?

We planned in advance to use repeated measures ANOVA (i.e. a mixed linear model on the condition means). But as the reviewer suggests, trial-wise mixed models can provide a much more sensitive test and account for the different numbers of valid trials between conditions and subjects. We performed this analysis. For velocity residuals we obtained the following results shown in Author response table 1:

In fact, for each variable, the pattern of significant effects turned out the same for both methods. Thus we added the following to the Materials and methods/analysis section:

“All statistical analyses were also performed using a full linear mixed effects model including each trial, which produced in qualitatively identical results.”

• I suggest that readers get access to uncorrected, observed velocity data rather than only the residuals.

We have included raw velocity as an extra panel in Figure 2, included the statistics in all main and supplementary results tables, and discussed this measure in the Results:

“Raw peak velocity had an effect of motivation, as both types of motivation increased speed (Figure 2F, p=0.0110), although this will include effects of changes in amplitude (via the main sequence) which showed a borderline significant effect of motivation (Figure 2C, p=0.0607).”

• While individual datapoints are presented in the supplement, I see no principled reason to present aggregate dataplots in the main text. Why not move the supplementary figures with actual datapoints to the main text? Raincloud plots might increase the readability of these plots?

We have added individual data points to the line graphs in Figure 2 (raincloud plots were very busy due to the 2*2*3 design). A few HC had strong motivation effects, which expanded the y-axes a lot, making the effects harder to see (see Author response image 1 for example),

Author response image 1

Download asset Open asset

So we have put the HC data on a separate panel (Figure 2B) to the PD data (Figure 2A) which we hope will be acceptable.The correlation plots already show individual data, but we were unable to include individual participants’ timecourses of velocity, acceleration, autocorrelation, or pupillometry on the respective figures as they swamped the means. Instead, we have added figure supplements showing these individual data, which we hope will be acceptable.

Figure 3—figure supplement 1 and Figure 6—figure supplement 2 are the new supplementary figures showing individual velocity and acceleration data, and pupil dilatation.

While making the individual pupillometry and autocorrelation plots, we realised we had not excluded the 4 PD and 1 HC, as we had for the main analyses. We have now updated our analyses and figures to have 26 PD and 29 HC to match the main saccade data. This affects Figures 4 and 6 only, and has not changed the findings except that PD OFF now have a significant cluster of higher autocorrelation at the beginning of the saccade for guaranteed motivation (Figure 4).

This increase when off (panel g) now matches the significant effect of dopamine (panel e) found when comparing PD ON vs OFF autocorrelations, so has not changed our interpretation. We have added:

“This coincides with the greater acceleration PD OFF patients had at the beginning of saccades to guaranteed rewards (Figure 3D), as faster movements have greater motor noise (Harris and Wolpert, 1998, 2006).”

The pupil size text has not changed.

Author details

1. John P Grogan

   Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom

   Contribution

   Resources, Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing

   For correspondence

   john.grogan@ndcn.ox.ac.uk

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-0463-8904

2. Timothy R Sandhu

   1. Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
   2. Department of Psychology, University of Cambridge, Cambridge, United Kingdom

   Contribution

   Data curation, Investigation, Methodology, Writing - review and editing

   Competing interests

   No competing interests declared

3. Michele T Hu

   1. Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
   2. Oxford Parkinson’s Disease Centre, University of Oxford, Oxford, United Kingdom

   Contribution

   Resources, Writing - review and editing

   Competing interests

   MTH is a consultant advisor to the Roche Prodromal Advisory, Biogen Digital Advisory Board, Evidera, and CuraSen Therapeutics, Inc.

4. Sanjay G Manohar

   1. Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
   2. Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom

   Contribution

   Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing - review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-0735-4349

• 4,003

  Page views

• 328

  Downloads

• 9

  Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.